Claim Verification:

FLARIN (200mg soft capsules)
FLARIN Joint & Muscular Pain Relief (200mg soft capsules)

The Proprietary Association of Great Britain (PAGB) and the Committee of Advertising Practice (CAP) requires that claims that involve comparisons with potentially identifiable products can be verified by consumers. Infirst Ltd are currently using the following claims which are supported by the information summarised below.


‘No other ibuprofen proven to be more effective for joint pain’ or ‘No other ibuprofen is more effective for joint pain’ or ‘For joint pain, as effective as twice the dose of standard ibuprofen’

Infirst Ltd have conducted a clinical trial in 462 patients with knee pain (the FLARE study). This trial compared joint pain relief with Flarin (2x200mg lipid capsules 3 times a day for 5 days) with either the same dose of standard ibuprofen liquid capsules (1x400mg liquid capsules 3 times a day for 5 days) or a higher dose of ibuprofen liquid capsules (2x400mg liquid capsules 3 times a day for 5 days). The results of the study showed that Flarin capsules (1200mg/day) are as effective as the prescription dose of standard liquid capsules (2400mg/day). The highest dose of ibuprofen that can be purchased without a prescription is 400mg (1200mg/day).

Infirst have conducted a review of  all the ibuprofen joint pain clinical trials published  over the last 10 years (July 2019) and found no evidence of any trials that would dispute this statement.  

The full results of the FLARE study can be accessed here